Barclays’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-12,400
Closed -$1.64M 7601
2018
Q4
$1.64M Sell
12,400
-5,900
-32% -$756K ﹤0.01% 2610
2018
Q3
$2.44M Sell
18,300
-200
-1% -$30K ﹤0.01% 2641
2018
Q2
$2.94M Buy
18,500
+12,600
+214% +$1.87M ﹤0.01% 2195
2018
Q1
$844K Sell
5,900
-1,800
-23% -$246K ﹤0.01% 3418
2017
Q4
$1.02M Buy
7,700
+700
+10% +$89.5K ﹤0.01% 3089
2017
Q3
$871K Sell
7,000
-4,300
-38% -$592K ﹤0.01% 3129
2017
Q2
$1.59M Buy
11,300
+1,900
+20% +$237K ﹤0.01% 2455
2017
Q1
$1.06M Sell
9,400
-7,100
-43% -$828K ﹤0.01% 2680
2016
Q4
$1.74M Buy
16,500
+7,700
+88% +$828K ﹤0.01% 2250
2016
Q3
$1.11M Sell
8,800
-37,800
-81% -$4.81M ﹤0.01% 2534
2016
Q2
$6.43M Buy
46,600
+35,300
+312% +$4.67M 0.01% 1138
2016
Q1
$1.56M Sell
11,300
-84,300
-88% -$11.6M ﹤0.01% 2146
2015
Q4
$15.3M Sell
95,600
-2,900
-3% -$448K 0.02% 686
2015
Q3
$13.1M Buy
98,500
+73,400
+292% +$9.58M 0.02% 796
2015
Q2
$2.86M Sell
25,100
-13,700
-35% -$1.64M ﹤0.01% 1926
2015
Q1
$4.62M Buy
38,800
+16,900
+77% +$2.25M 0.01% 1629
2014
Q4
$3.18M Sell
21,900
-8,500
-28% -$1.07M ﹤0.01% 2110
2014
Q3
$3.98M Sell
30,400
-188,400
-86% -$24.8M ﹤0.01% 1997
2014
Q2
$27.4M Buy
218,800
+114,400
+110% +$14.8M 0.03% 543
2014
Q1
$16.7M Sell
104,400
-678,200
-87% -$112M 0.02% 802
2013
Q4
$105M Buy
782,600
+103,100
+15% +$13.2M 0.11% 148
2013
Q3
$73.4M Buy
679,500
+394,400
+138% +$42.6M 0.09% 192
2013
Q2
$24.2M Buy
+285,100
New +$25.5M 0.03% 560

Barclays's ATHN Position: Q1 2019 in Review

Barclays sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 72,825 shares — an estimated $9.61M sold.

Barclays first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $28.8M in Q1 2014. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Barclays reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Barclays sold 72,825 Athenahealth, Inc. shares in Q1 2019, an estimated $9.61M.
  • Barclays first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
  • Barclays's Athenahealth, Inc. position peaked at $28.8M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.